Cartesian Therapeutics (RNAC) AGM 2026 summary

Opening remarks and agenda

• CEO and Chairman welcomed attendees, introduced board members, and outlined meeting procedures.

• Independent auditors from Ernst & Young were introduced and made available for questions.

Corporate governance

• Inspector of Election from Broadridge Financial Solutions confirmed a quorum and proper delivery of meeting materials.

• Only stockholders of record as of April 14, 2026, or valid proxy holders, were eligible to vote.

• Voting was conducted electronically, with polls open during the meeting.

Board and executive committee updates

• Election of three Class I directors for terms expiring at the 2029 annual meeting was proposed.

• Board unanimously recommended all director nominees.